90 related articles for article (PubMed ID: 15653132)
1. Release of indomethacin from ultrasound dry granules containing lactose-based excipients.
Cavallari C; Albertini B; Rodriguez L; Rabasco AM; Fini A
J Control Release; 2005 Jan; 102(1):39-47. PubMed ID: 15653132
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-compacted indomethacin/polyvinylpyrrolidone systems: effect of compaction process on particle morphology and dissolution behavior.
Fini A; Holgado MA; Rodriguez L; Cavallari C
J Pharm Sci; 2002 Aug; 91(8):1880-90. PubMed ID: 12115815
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose.
Allahham A; Stewart PJ
Eur J Pharm Biopharm; 2007 Nov; 67(3):732-42. PubMed ID: 17540551
[TBL] [Abstract][Full Text] [Related]
4. Effect of drug particle size in ultrasound compacted tablets. Continuum percolation model approach.
Millán M; Caraballo I
Int J Pharm; 2006 Mar; 310(1-2):168-74. PubMed ID: 16431046
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of beta-lactose, PVP K12 and PVP K90 as excipients to prepare piroxicam granules using two wet granulation techniques.
Albertini B; Cavallari C; Passerini N; González-Rodríguez ML; Rodriguez L
Eur J Pharm Biopharm; 2003 Nov; 56(3):479-87. PubMed ID: 14602193
[TBL] [Abstract][Full Text] [Related]
6. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.
Tay T; Allahham A; Morton DA; Stewart PJ
Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348
[TBL] [Abstract][Full Text] [Related]
7. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets.
Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS
Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740
[TBL] [Abstract][Full Text] [Related]
8. A comparison of drug loading capacity of cellactose with two ad hoc processed lactose-cellulose direct compression excipients.
Casalderrey M; Souto C; Concheiro A; Gómez-Amoza JL; Martínez-Pacheco R
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):398-401. PubMed ID: 15056951
[TBL] [Abstract][Full Text] [Related]
9. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.
Peerapattana J; Otsuka K; Otsuka M
Biomed Mater Eng; 2004; 14(3):293-301. PubMed ID: 15299241
[TBL] [Abstract][Full Text] [Related]
10. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
Lu B; Wen R; Yang H; He Y
Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
[TBL] [Abstract][Full Text] [Related]
12. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
13. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
Thumma S; Repka MA
Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
[TBL] [Abstract][Full Text] [Related]
14. DISSOLUTION AND COMPATIBILITY STUDY OF BINARY AND TERNARY INTERACTIVE MIXTURES OF INDOMETHACIN: COMPARISON WITH COMMERCIALLY AVAILABLE CAPSULES.
Maswadeh HM
Acta Pol Pharm; 2016; 73(3):739-48. PubMed ID: 27476292
[TBL] [Abstract][Full Text] [Related]
15. Elaboration and structural analysis of aquasomes loaded with indomethacin.
Rojas-Oviedo I; Salazar-López RA; Reyes-Gasga J; Quirino-Barreda CT
Eur J Pharm Sci; 2007 Nov; 32(3):223-30. PubMed ID: 17905573
[TBL] [Abstract][Full Text] [Related]
16. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.
Tay T; Allahham A; Morton DA; Stewart PJ
J Pharm Sci; 2011 Oct; 100(10):4269-80. PubMed ID: 21560127
[TBL] [Abstract][Full Text] [Related]
17. The effects of high shear blending on alpha-lactose monohydrate.
Bridson RH; Robbins PT; Chen Y; Westerman D; Gillham CR; Roche TC; Seville JP
Int J Pharm; 2007 Jul; 339(1-2):84-90. PubMed ID: 17398047
[TBL] [Abstract][Full Text] [Related]
18. HyperDSC studies of amorphous polyvinylpyrrolidone in a model wet granulation system.
Buckton G; Adeniyi AA; Saunders M; Ambarkhane A
Int J Pharm; 2006 Apr; 312(1-2):61-5. PubMed ID: 16500057
[TBL] [Abstract][Full Text] [Related]
19. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.
Vogt M; Kunath K; Dressman JB
Eur J Pharm Biopharm; 2008 Feb; 68(2):330-7. PubMed ID: 17574401
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-compacted and spray-congealed indomethacin/polyethyleneglycol systems.
Fini A; Rodriguez L; Cavallari C; Albertini B; Passerini N
Int J Pharm; 2002 Oct; 247(1-2):11-22. PubMed ID: 12429481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
